PE20020157A1 - Compuestos derivados de piridona como inhibidores de proteasas de picornaviral 3c, composiciones, sus usos farmaceuticos y materiales para su sintesis - Google Patents
Compuestos derivados de piridona como inhibidores de proteasas de picornaviral 3c, composiciones, sus usos farmaceuticos y materiales para su sintesisInfo
- Publication number
- PE20020157A1 PE20020157A1 PE2000001276A PE0012762000A PE20020157A1 PE 20020157 A1 PE20020157 A1 PE 20020157A1 PE 2000001276 A PE2000001276 A PE 2000001276A PE 0012762000 A PE0012762000 A PE 0012762000A PE 20020157 A1 PE20020157 A1 PE 20020157A1
- Authority
- PE
- Peru
- Prior art keywords
- picornaviral
- alkyl
- synthesis
- compositions
- materials
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 241001144416 Picornavirales Species 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- JMFJXZKGJLFGEJ-UHFFFAOYSA-N isocyanic acid;pyridine Chemical compound N=C=O.C1=CC=NC=C1 JMFJXZKGJLFGEJ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A CARBONILAMINO PIRIDIN 2-OXO DE FORMULA I DONDE Ra ES HETEROCICLOALQUILO, HETEROCICLOALQUILALQUILO; Rb ES UN GRUPO a; Ri, Rg SON H, ALQUILO; m ES 0-1; p ES 0-5; A1 ES CH, N; A2 Y A3 SON C(Rh)(Ri), NRj, SO, SO2; Rh, Ri, Rj SON H, ALQUILO; CUANDO p ES 1-5; A4 ES N(Rk)(Rl), C(Rh)(Ri)(Rj), ORi; Rk Y Rl SON H, ALQUILO, ARILO, ACILO; Rc ES H, HALOGENO, ALQUILO; Rd ES H, HALOGENO, HIDROXILO, ENTRE OTROS; Re ES H, ALQUILO; Z Y Z1 SON H, F, ALQUILO, ENTRE OTROS; Z Y Rd O Z Y Z1 JUNTOS FORMAN CICLOALQUILO, HETEROCICLOALQUILO; SON COMPUESTOS PREFERIDOS DE FORMULA II, ENTRE OTROS, EL COMPUESTO I ES UN INHIBIDOR DE PICORNAVIRAL 3C PROTEASA (RINOVIRUS 3C PROTEASA) Y PUEDE SER UTIL PARA EL TRATAMIENTO DE INFECCIONES RINOVIRALES
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16898699P | 1999-12-03 | 1999-12-03 | |
| US19205200P | 2000-03-24 | 2000-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020157A1 true PE20020157A1 (es) | 2002-02-22 |
Family
ID=26864652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000001276A PE20020157A1 (es) | 1999-12-03 | 2000-11-30 | Compuestos derivados de piridona como inhibidores de proteasas de picornaviral 3c, composiciones, sus usos farmaceuticos y materiales para su sintesis |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6514997B2 (es) |
| EP (1) | EP1252145A1 (es) |
| JP (1) | JP2003515591A (es) |
| KR (1) | KR20020058076A (es) |
| CN (1) | CN1402710A (es) |
| AP (1) | AP2002002510A0 (es) |
| AR (1) | AR030540A1 (es) |
| AU (1) | AU777943B2 (es) |
| BG (1) | BG106754A (es) |
| BR (1) | BR0016742A (es) |
| CA (1) | CA2392504A1 (es) |
| CO (1) | CO5261566A1 (es) |
| CZ (1) | CZ20021906A3 (es) |
| DO (1) | DOP2000000108A (es) |
| EA (1) | EA200200625A1 (es) |
| EE (1) | EE200200281A (es) |
| HK (1) | HK1052933A1 (es) |
| HU (1) | HUP0204006A3 (es) |
| IL (1) | IL149427A0 (es) |
| IS (1) | IS6378A (es) |
| MX (1) | MXPA02005124A (es) |
| NO (1) | NO20022589L (es) |
| NZ (1) | NZ518934A (es) |
| OA (1) | OA12101A (es) |
| PA (1) | PA8507801A1 (es) |
| PE (1) | PE20020157A1 (es) |
| PL (1) | PL356062A1 (es) |
| SK (1) | SK7602002A3 (es) |
| UY (1) | UY26465A1 (es) |
| WO (1) | WO2001040189A1 (es) |
| YU (1) | YU40002A (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1073672B1 (en) | 1998-04-30 | 2003-08-27 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, their preparation and use |
| PE20011277A1 (es) | 2000-04-14 | 2002-01-07 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
| JP2004503533A (ja) * | 2000-06-14 | 2004-02-05 | アグロン・ファーマシュウティカルズ・インコーポレーテッド | 抗ピコルナウイルス化合物及び組成物、その医薬的使用、並びにその合成のための物質 |
| DK1357111T3 (da) * | 2000-12-28 | 2009-11-02 | Shionogi & Co | 2-pyridonderivater med affinitet for cannabinoid type 2-receptor |
| AU2003243657A1 (en) * | 2002-06-26 | 2004-01-19 | Bristol-Myers Squibb Company | Amino-bicyclic pyrazinones and pyridinones |
| EP1606019A1 (en) * | 2003-03-07 | 2005-12-21 | The University Court of The University of Aberdeen | Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
| WO2004093860A1 (en) * | 2003-04-21 | 2004-11-04 | Pfizer Inc. | Inhibitors of sars related coronavirus proteinase |
| US20040235952A1 (en) * | 2003-05-05 | 2004-11-25 | Agouron Pharmaceuticals, Inc. | Inhibitors of severe acute respiratory syndrome (SARS) 3C-like proteinase |
| EP1704142A4 (en) * | 2003-12-31 | 2008-08-20 | Taigen Biotechnology Co Ltd | PROTEASE INHIBITORS |
| US7462594B2 (en) * | 2003-12-31 | 2008-12-09 | Taigen Biotechnology Co., Ltd. | Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
| WO2005110988A1 (en) * | 2004-05-07 | 2005-11-24 | Janssen Pharmaceutica, N.V. | Pyridone compounds as inhibitors of bacterial type iii protein secretion systems |
| GB0702862D0 (en) * | 2007-02-14 | 2007-03-28 | Univ Aberdeen | Therapeutic compounds |
| KR100891699B1 (ko) | 2007-04-10 | 2009-04-03 | 광주과학기술원 | 7-아미노-4-((ｓ)-3-(4-플루오로페닐)-2-((r)-3-메틸-2-(5-메틸이소옥사졸-3-카복사미도)부탄아미도)프로판아미도)-7-옥소-2-헵테노에이트 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 및 치료용 약학적 조성물 |
| AU2009285584B2 (en) * | 2008-08-29 | 2015-04-02 | Treventis Corporation | Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system |
| KR101385855B1 (ko) * | 2012-10-16 | 2014-04-22 | 이동익 | 카뎁신 검출용 다이아로마틱 아미노산 기질 |
| EP3455205A4 (en) | 2016-05-13 | 2020-01-01 | Emory University | PEPTIDOMIMETICS FOR TREATING A NOVOVIRUS INFECTION |
| US11124497B1 (en) | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| MX2022013081A (es) * | 2020-04-23 | 2022-11-10 | Purdue Research Foundation | Compuestos para el tratamiento de sars. |
| US11174231B1 (en) | 2020-06-09 | 2021-11-16 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4652676A (en) | 1985-05-06 | 1987-03-24 | General Foods Corporation | L-aminodicarboxylic acid alkenes |
| US5374623A (en) | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
| US5514778A (en) | 1993-07-01 | 1996-05-07 | Eli Lilly And Company | Anti-picornaviral agents |
| US5486623A (en) | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
| IL112759A0 (en) | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
| IT1269511B (it) | 1994-05-17 | 1997-04-01 | Univ Degli Studi Milano | Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione |
| US5498616A (en) | 1994-11-04 | 1996-03-12 | Cephalon, Inc. | Cysteine protease and serine protease inhibitors |
| AU5122196A (en) | 1995-03-31 | 1996-10-16 | Takeda Chemical Industries Ltd. | Cysteine protease inhibitor |
| IT1281031B1 (it) | 1995-11-17 | 1998-02-11 | Carlo Chiaves | Struttura prefabbricata per la realizzazione di opere costruite a cielo aperto, particolarmente per cavalcavia autostradali, |
| DE69733137T2 (de) * | 1996-05-14 | 2006-03-02 | Agouron Pharmaceuticals, Inc., San Diego | Inhibitoren von picornavirus 3c protease und verfahren zur herstellung und verwendung |
| US5856530A (en) | 1996-05-14 | 1999-01-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| WO1997049668A1 (en) | 1996-06-13 | 1997-12-31 | Smithkline Beecham Corporation | Inhibitiors of cysteine protease |
| US6020371A (en) | 1997-03-28 | 2000-02-01 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds compositions containing them and methods for their use |
| CA2289541A1 (en) * | 1997-03-28 | 1998-10-08 | Peter S. Dragovich | Antipicornaviral compouds, compositions containing them, and methods for their use |
| US6331554B1 (en) | 1997-03-28 | 2001-12-18 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, compositions containing them, and methods for their use |
| US5962487A (en) | 1997-12-16 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| EP1073672B1 (en) * | 1998-04-30 | 2003-08-27 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, their preparation and use |
| US6369226B1 (en) | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
| DK1206484T3 (da) | 1999-08-04 | 2005-01-24 | Agouron Pharma | Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese |
| PE20010517A1 (es) | 1999-08-24 | 2001-05-16 | Agouron Pharma | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves |
| KR20020030795A (ko) | 1999-08-24 | 2002-04-25 | 개리 이. 프라이드만 | 이소옥사졸카록스아미드 및 유사체의 제조를 위한중간물질 및 제조방법 |
-
2000
- 2000-11-30 PA PA20008507801A patent/PA8507801A1/es unknown
- 2000-11-30 PE PE2000001276A patent/PE20020157A1/es not_active Application Discontinuation
- 2000-12-01 HK HK03104911.5A patent/HK1052933A1/zh unknown
- 2000-12-01 OA OA1200200160A patent/OA12101A/en unknown
- 2000-12-01 UY UY26465A patent/UY26465A1/es not_active Application Discontinuation
- 2000-12-01 EA EA200200625A patent/EA200200625A1/ru unknown
- 2000-12-01 EP EP00980893A patent/EP1252145A1/en not_active Withdrawn
- 2000-12-01 WO PCT/US2000/032621 patent/WO2001040189A1/en not_active Ceased
- 2000-12-01 JP JP2001541874A patent/JP2003515591A/ja not_active Withdrawn
- 2000-12-01 YU YU40002A patent/YU40002A/sh unknown
- 2000-12-01 CZ CZ20021906A patent/CZ20021906A3/cs unknown
- 2000-12-01 CA CA002392504A patent/CA2392504A1/en not_active Abandoned
- 2000-12-01 BR BR0016742-8A patent/BR0016742A/pt not_active IP Right Cessation
- 2000-12-01 AU AU18094/01A patent/AU777943B2/en not_active Ceased
- 2000-12-01 KR KR1020027007099A patent/KR20020058076A/ko not_active Withdrawn
- 2000-12-01 IL IL14942700A patent/IL149427A0/xx unknown
- 2000-12-01 CN CN00816602A patent/CN1402710A/zh active Pending
- 2000-12-01 NZ NZ518934A patent/NZ518934A/en unknown
- 2000-12-01 HU HU0204006A patent/HUP0204006A3/hu unknown
- 2000-12-01 AP APAP/P/2002/002510A patent/AP2002002510A0/en unknown
- 2000-12-01 DO DO2000000108A patent/DOP2000000108A/es unknown
- 2000-12-01 EE EEP200200281A patent/EE200200281A/xx unknown
- 2000-12-01 PL PL00356062A patent/PL356062A1/xx not_active Application Discontinuation
- 2000-12-01 SK SK760-2002A patent/SK7602002A3/sk unknown
- 2000-12-01 MX MXPA02005124A patent/MXPA02005124A/es not_active Application Discontinuation
- 2000-12-01 US US09/726,376 patent/US6514997B2/en not_active Expired - Fee Related
- 2000-12-04 AR ARP000106412A patent/AR030540A1/es unknown
- 2000-12-04 CO CO00092264A patent/CO5261566A1/es not_active Application Discontinuation
-
2002
- 2002-05-10 IS IS6378A patent/IS6378A/is unknown
- 2002-05-30 BG BG106754A patent/BG106754A/bg unknown
- 2002-05-31 NO NO20022589A patent/NO20022589L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02005124A (es) | 2003-01-28 |
| OA12101A (en) | 2006-05-04 |
| HUP0204006A2 (hu) | 2003-03-28 |
| YU40002A (sh) | 2006-01-16 |
| US6514997B2 (en) | 2003-02-04 |
| AP2002002510A0 (en) | 2002-06-30 |
| HK1052933A1 (zh) | 2003-10-03 |
| UY26465A1 (es) | 2001-06-29 |
| NO20022589L (no) | 2002-07-31 |
| PA8507801A1 (es) | 2002-08-26 |
| EA200200625A1 (ru) | 2002-12-26 |
| PL356062A1 (en) | 2004-06-14 |
| EP1252145A1 (en) | 2002-10-30 |
| IS6378A (is) | 2002-05-10 |
| NZ518934A (en) | 2003-11-28 |
| JP2003515591A (ja) | 2003-05-07 |
| AU777943B2 (en) | 2004-11-04 |
| WO2001040189A1 (en) | 2001-06-07 |
| DOP2000000108A (es) | 2003-03-15 |
| CN1402710A (zh) | 2003-03-12 |
| BR0016742A (pt) | 2002-09-03 |
| CA2392504A1 (en) | 2001-06-07 |
| IL149427A0 (en) | 2002-11-10 |
| HUP0204006A3 (en) | 2004-11-29 |
| EE200200281A (et) | 2003-06-16 |
| CZ20021906A3 (cs) | 2003-02-12 |
| NO20022589D0 (no) | 2002-05-31 |
| AR030540A1 (es) | 2003-08-27 |
| BG106754A (bg) | 2003-07-31 |
| SK7602002A3 (en) | 2003-02-04 |
| KR20020058076A (ko) | 2002-07-12 |
| US20010047006A1 (en) | 2001-11-29 |
| CO5261566A1 (es) | 2003-03-31 |
| AU1809401A (en) | 2001-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020157A1 (es) | Compuestos derivados de piridona como inhibidores de proteasas de picornaviral 3c, composiciones, sus usos farmaceuticos y materiales para su sintesis | |
| AR047056A1 (es) | Derivados de pirimidinas condensadas. composiciones farmacéuticas | |
| ATE448225T1 (de) | Aza-bicycloalkylether und deren verwendung als alpha7-nachr agonisten | |
| AR023152A1 (es) | Compuesto tienopirimidina, procedimiento para producirlo, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dichacomposicion | |
| ES337526A1 (es) | Un procedimiento para la manufactura de nuevas piperazinas. | |
| CO6321258A2 (es) | Benzofuropirimidinonas como inhibidores de proteina de quinasa | |
| KR910020009A (ko) | 비사이클릭 1-아자-사이클로알칸 | |
| AR023308A1 (es) | Uso de dihidropirimidinas para la preparacion de un medicamento, dihidropirimidinas, procedimiento para su produccion y preparados farmaceuticos que loscontienen. | |
| AR080596A1 (es) | Compuestos alquilamido y composiciones farmaceuticas | |
| AR060562A1 (es) | Compuestos heterociclicos como antagonistas del receptor il-8. procesos de obtencion y composiciones farmaceuticas. | |
| NO20001402L (no) | Substituerte kromanderivater | |
| AR041883A1 (es) | Compuestos de piridopirimidinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| ES8207147A1 (es) | Un procedimiento para la preparacion de imidazolilfenilamidinas. | |
| ES519491A0 (es) | Un metodo para preparar compuesto de piridilo. | |
| DK304289A (da) | Benzenderivater | |
| CO5540385A2 (es) | Derivados quirales de acido oxazol arilpropionico, su metodo de sintesis ycomposiciones farmaceuticas que los contienen | |
| NZ227400A (en) | Thiol-ketone and thiol-aldehyde derivatives, intermediates thereof and pharmaceutical compositions | |
| WO2010082212A3 (en) | N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses | |
| AR128323A1 (es) | Inhibidores de parp7 | |
| AR035692A1 (es) | Derivados de 2,5-dioxo imidazolidina, un procedimiento para su preparacion, y composiciones farmaceuticas que los contienen. | |
| AR003532A1 (es) | Nuevos derivados de acido carboxilico | |
| JPH03204881A (ja) | オキサゾロピリジン誘導体の新規合成方法 | |
| NO20080677L (no) | Ny 1H-indol-pyridinkarboksamid og 1H-indol-piperidinkarboksamidforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger som inneholder dem | |
| DK1266896T3 (da) | Lineære eller cykliske urinstoffer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse | |
| ATE291577T1 (de) | Cyanoindol-derivate als inhibitoren der wiederaufnahme von serotonin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |